参考文献/References:
[1] 黄南,王晓龙,李文静,等.泻痰清肺方对支气管哮喘患者血清TNF-α和IL-8水平的影响[J].陕西中医,2017,38(5):588-589.
[2] 温思露,李芬,邓玉琴,等.miRNA和lncRNA调控巨噬细胞极化在变应性疾病中的作用[J].中华临床免疫和变态反应杂志,2023,17(3):266-274.
[3] PEI W,LI X,BI R,et al.Exosome membrane-modified M2 macrophages targeted nanomedicine:Treatment for allergic asthma[J].J Control Release,2021,338:253-267.
[4] GAO J,ZHANG H,ZHANG F.Research progress of TIPE2 in immune-related diseases[J].Int Immunopharmacol,2023,121:110514.
[5] SHI B,HAO Y,LI W,et al.TIPE2 may target the Nrf2/HO-1 pathway to inhibit M1 macrophage-related neutrophilic inflammation in asthma[J].Front Immunol,2022,13:883885.
[6] WEN J H,LI D Y,LIANG S.Macrophage autophagy in macrophage polarization,chronic inflammation and organ fibrosis[J].Front Immunol,2022,13:946832.
[7] 申昆玲,邓力,李云珠,等.糖皮质激素雾化吸入疗法在儿科应用的专家共识(2018年修订版)[J].临床儿科杂志,2018,36(2):95-107.
[8] HAN X,LIU L,HUANG S,et al.RNA m6A methylation modulates airway inflammation in allergic asthma via PTX3-dependent macrophage homeostasis[J].Nat Commun,2023,14(1):7328.
[9] SAVIN I A,ZENKOVA M A,SENKOVA A V.Bronchial asthma,airway remodeling and lung fibrosis as successive steps of one process[J].Int J Mol Sci,2023,24(22):16042.
[10] 盖娜,王琰华,王潇健,等.血清骨膜蛋白、微小RNA-155与支气管哮喘急性发作期患儿肺功能和免疫功能及预后相关性研究[J].陕西医学杂志,2023,52(12):1684-1687.
[11] 谢勇,郭丽丽.支气管哮喘合并肺炎支原体感染患儿糖皮质激素受体α、β mRNA表达检测及其与血清炎症因子、肺功能相关性分析[J].陕西医学杂志,2022,51(9):1142-1145.
[12] 武玉刚,朱玉龙,马红霞.祛风止痉胶囊对支气管哮喘大鼠气道炎症及TRPV1通路的影响[J].陕西中医,2024,45(4):463-467.
[13] CHEN M L,NOPSOPON T,AKENROYE A.Incidence of anti-drug antibodies to monoclonal antibodies in asthma:A systematic review and meta-analysis[J].J Allergy Clin Immunol Pract,2023,11(5):1475-1484.
[14] 杨霞,宁宗.巨噬细胞极化调控信号通路及M2/M1失衡在肺部炎症性疾病中作用的研究进展[J].山东医药,2023,63(26):88-91.
[15] NOPSOPON T,LASSITER G,CHEN ML,et al.Comparative efficacy of tezepelumab to mepolizumab,benralizumab,and dupilumab in eosinophilic asthma:A bayesian network meta-analysis[J].J Allergy Clin Immunol,2023,151(3):747-755.
[16] WANG H,ZHONG B,GENG Y,et al.TIPE2 inhibits PDGF-BB-induced phenotype switching in airway smooth muscle cells through the PI3K/Akt signaling pathway[J].Respir Res,2021,22(1):238.
[17] LIU Y,SONG J,YANG J.Tumor necrosis factor α-induced protein 8-like 2 alleviates nonalcoholic fatty liver disease through suppressing transforming growth factor beta-activated kinase 1 activation[J].Hepatology,2021,74(3):1300-1318.
[18] CONG L,XIE X,LIU S.Genistein promotes M1 macrophage apoptosis and reduces inflammatory response by disrupting miR-21/TIPE2 pathway[J].Saudi Pharm J,2022,30(7):934-945.
[19] KOREVAAR D A,DAMEN J A,HEUS P,et al.Effectiveness of FeNO-guided treatment in adult asthma patients:A systematic review and meta-analysis[J].Clin Exp Allergy,2023,53(8):798-808.
[20] MURUGESAN N,SAXENA D,DILEEP A,et al.Update on the role of FeNO in asthma management[J].Diagnostics(Basel)2023,13(8):1428.
[21] GAO J,WANG N,ZONG F,et al.TIPE2 regulates the response of BV2 cells to lipopolysaccharide by the crosstalk between PI3K/AKT signaling and microglia M1/M2 polarization[J].Int Immunopharmacol,2023,120:110389.
[22] ABDELAZIZ M H,JI X,WAN J,et al.Mycobacterium-induced Th1,helminths-induced Th2 cells and the potential vaccine candidates for allergic asthma:Imitation of natural infection[J].Front Immunol,2021,12:696734.
[23] HOU Y,WEI D,ZHANG Z,et al.FABP5 controls macrophage alternative activation and allergic asthma by selectively programming long-chain unsaturated fatty acid metabolism[J].Cell Rep,2022,41(7):111668.
[24] LUO W,HU J,XU W,et al.Distinct spatial and temporal roles for Th1,Th2,and Th17 cells in asthma[J].Front Immunol,2022,13:974066.
[25] HOSEINI-SHAHRESTANAK S,BAZARGAN N,RAHIMIAN L,et al.Imbalanced expression of Th2 and Treg cell-related parameters in peripheral blood mononuclear cells in patients with allergic asthma[J].Tanaffos,2018,17(1):1-12.
[26] HE Y,GAO Y,ZHANG Q,et al.IL-4 switches microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH[J].Neuroscience,2020,437:161-171.
[27] CHEN D,CHEN Q,ZHAO K,et al.Exploring the mechanism of xiaoqinglong decoction in the treatment of infantile asthma based on network pharmacology and molecular docking[J].Medicine(Baltimore),2023,102(2):e32623.